Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19
This report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Indian Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=8;spage=3134;epage=3136;aulast=Eduarda |
| _version_ | 1798038597209686016 |
|---|---|
| author | Maria Eduarda Andrade e Andrade Juliane Cardoso Rodrigues Elvio Ferreira Junior Mario Henrique Camargos de Lima |
| author_facet | Maria Eduarda Andrade e Andrade Juliane Cardoso Rodrigues Elvio Ferreira Junior Mario Henrique Camargos de Lima |
| author_sort | Maria Eduarda Andrade e Andrade |
| collection | DOAJ |
| description | This report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and no other factor that could lead to the findings on his examinations. After treatment with high doses of topic, oral, and sub-conjunctival corticoids, the patient had a favorable therapeutic response. The signs of corneal transplant rejection must be oriented to the patients and the causing factors actively searched by ophthalmologists so that treatment is rapidly initiated and sequels are avoided. This report raises the question if these events are correlated and whether the patient should receive the second dose of the vaccine against SARS-CoV-2 or not. |
| first_indexed | 2024-04-11T21:42:21Z |
| format | Article |
| id | doaj.art-b8258f2d8dee4ce9b3cd1e05beb33832 |
| institution | Directory Open Access Journal |
| issn | 0301-4738 1998-3689 |
| language | English |
| last_indexed | 2024-04-11T21:42:21Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Ophthalmology |
| spelling | doaj.art-b8258f2d8dee4ce9b3cd1e05beb338322022-12-22T04:01:34ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892022-01-017083134313610.4103/ijo.IJO_1021_22Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19Maria Eduarda Andrade e AndradeJuliane Cardoso RodriguesElvio Ferreira JuniorMario Henrique Camargos de LimaThis report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and no other factor that could lead to the findings on his examinations. After treatment with high doses of topic, oral, and sub-conjunctival corticoids, the patient had a favorable therapeutic response. The signs of corneal transplant rejection must be oriented to the patients and the causing factors actively searched by ophthalmologists so that treatment is rapidly initiated and sequels are avoided. This report raises the question if these events are correlated and whether the patient should receive the second dose of the vaccine against SARS-CoV-2 or not.http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=8;spage=3134;epage=3136;aulast=Eduardabnt162b2 vaccinecoronaviruskeratoplastypenetratingvaccine |
| spellingShingle | Maria Eduarda Andrade e Andrade Juliane Cardoso Rodrigues Elvio Ferreira Junior Mario Henrique Camargos de Lima Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 Indian Journal of Ophthalmology bnt162b2 vaccine coronavirus keratoplasty penetrating vaccine |
| title | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
| title_full | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
| title_fullStr | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
| title_full_unstemmed | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
| title_short | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
| title_sort | keratoplasty rejection after messenger rna vaccine bnt162b2 for covid 19 |
| topic | bnt162b2 vaccine coronavirus keratoplasty penetrating vaccine |
| url | http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=8;spage=3134;epage=3136;aulast=Eduarda |
| work_keys_str_mv | AT mariaeduardaandradeeandrade keratoplastyrejectionaftermessengerrnavaccinebnt162b2forcovid19 AT julianecardosorodrigues keratoplastyrejectionaftermessengerrnavaccinebnt162b2forcovid19 AT elvioferreirajunior keratoplastyrejectionaftermessengerrnavaccinebnt162b2forcovid19 AT mariohenriquecamargosdelima keratoplastyrejectionaftermessengerrnavaccinebnt162b2forcovid19 |